Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by ledrogon Oct 23, 2017 9:19pm

41 Views

Post# 26847948

RE:RE:RE:RE:RE:this is the lab

Public money, private greed.....its all disclosed though, so those who risked money here can't really whine about it imo....like those promotional email blasts always say, investors should be willing to lose some or all of their investment....if its play money that people are punting, oh well....pumped up penny stocks or the slots, take your pick.

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions